# HANDOVER

## 1. Project

**BHIV Biotech — Drug Safety Evidence Integration Capability**

**Task ID:** BIOTECH-T3-SHRAVANI-DRUG-SAFETY

**Owner:** BHIV Biotech

**Implementation Scope:** Drug Safety / Pharmacovigilance Evidence Integration

---

## 2. Purpose

This project extends the existing Drug Safety and Quality Control evidence-processing work into a structured multi-source evidence integration capability.

The implementation provides a deterministic processing flow for:

* evidence normalization;
* provenance preservation;
* drug/product matching;
* evidence validation;
* duplicate detection;
* conflict detection;
* human-review flagging;
* structured evidence output;
* automated testing.

The system is intended to support evidence organization and review rather than replace qualified human or regulatory decision-making.

---

## 3. Current Processing Flow

```text
Evidence Input
      |
      v
Source / Provenance Capture
      |
      v
Evidence Normalization
      |
      v
Drug / Product Matching
      |
      v
Evidence Validation
      |
      v
Duplicate Detection
      |
      v
Conflict Detection
      |
      v
Human Review Flagging
      |
      v
Structured Evidence Output
```

---

## 4. Primary Entry Point

The primary integration implementation is:

```text
integration/evidence_integration.py
```

Supporting implementation modules are located in:

```text
normalization/
matching/
validation/
duplicates/
conflicts/
review/
schema/
```

---

## 5. Basic Execution

The existing Drug Safety tracker can be executed from the project root using:

```powershell
python drug_safety_tracker.py --file sample_data/evidence_records.csv --drug "Drug A"
```

The integration and validation functionality is covered by the automated test suite in:

```text
tests/
```

---

## 6. Important Outputs

Key generated outputs include:

```text
integration/integrated_evidence_output.json
integration/output_run_1.json
normalized_data/normalized_evidence.json
```

Runtime evidence is stored in:

```text
evidence_packet/runtime_logs/
```

The packaged implementation files are stored in:

```text
evidence_packet/code_packet/
```

---

## 7. Testing Status

The recorded testing results include:

* Automated tests: 23/23 PASS
* Validation tests: 12/12 PASS
* Drug/product matching tests: 4/4 PASS
* Human-review tests: 4/4 PASS
* Integration runtime: PASS
* Deterministic replay: PASS

Detailed test documentation is available in:

```text
TEST_RESULTS.md
tests/test_results.md
evidence_packet/TEST_RESULTS.md
```

---

## 8. Review and Evidence Package

Important review documentation is located at:

```text
review_packets/REVIEW_PACKET.md
evidence_packet/review_packet.md
CODE_PACKET_INDEX.md
```

The evidence packet also contains:

```text
evidence_packet/
├── code_packet/
├── runtime_logs/
├── api_samples/
├── deployment_proof/
└── screenshots/
```

The screenshots directory is reserved for required visual execution evidence.

---

## 9. Current Limitations

* The implementation is a local Windows/Python execution environment.
* No production deployment has been performed or verified.
* No live external API integration has been claimed.
* A human-review flag does not establish clinical causality, clinical safety, or regulatory significance.
* Structural validation verifies data-quality requirements and does not scientifically validate the underlying evidence.
* Conflicting evidence is preserved rather than silently deleted.
* The implementation does not automatically make clinical or regulatory decisions.

---

## 10. Handover Notes

A reviewer or developer should begin with:

1. `README.md`
2. `ARCHITECTURE.md`
3. `INTEGRATION.md`
4. `CODE_PACKET_INDEX.md`
5. `TEST_RESULTS.md`
6. `review_packets/REVIEW_PACKET.md`

The implementation can then be traced from the integration entry point through normalization, matching, validation, duplicate/conflict detection, human-review handling, and structured output.

---

## 11. Final Status

The core Drug Safety Evidence Integration capability has been implemented and tested locally.

The remaining submission work consists of final documentation/requirement audit and the required screenshot evidence. No production deployment or live external API integration should be inferred from this local implementation.
